A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate the Safety of Fentanyl TAIFUN Treatment after Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Fentanyl; Fentanyl
- Indications Cancer pain
- Focus Adverse reactions
- Acronyms FIND-S
- 13 Jan 2009 Integrated information from ClinicalTrials.gov record.
- 14 Jul 2008 New trial record.